We Are Optimistic for the Business Overall, Says Bayer CEO

The CEO discusses the Monsanto acquisition, expressing no regrets despite stock performance and legal challenges. He emphasizes the company's strategic direction, focusing on integration and market leadership in life sciences. The CEO addresses investor concerns about company structure and operational challenges, reaffirming confidence in future growth and strategic plans.

What were the main concerns raised about the Monsanto purchase?

How does the company view its legal challenges in relation to its business outlook?

What factors contributed to the disappointing stock performance over the last five years?

What steps is the company taking to show its value to investors?

What is the company's strategy regarding the integration of its businesses?

How does the company plan to address the challenges in its consumer health and animal health divisions?

What are the expectations for the upcoming capital market event mentioned in the text?